Checkmate Pharmaceuticals IPO

Checkmate Pharmaceuticals is a clinical stage biopharmaceutical company focused on activation of innate immunity to treat cancer.

Total Funding to Date$82MM
Register for Details

For more details on financing and valuation for Checkmate Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in